Results 281 to 290 of about 370,325 (328)

Dermatological and gastrointestinal adverse reactions in ocrelizumab treated patients with multiple sclerosis: a case series. [PDF]

Front Immunol
Höpner LK, Marschall E, Schindler P, Frauendorf V, Böhmig M, Rakers F, Karimi D, Faber C, Ruprecht K, Otto C.   +9 more
europepmc   +1 more source

Pro‐Inflammatory Dietary Patterns Are Associated With Atopic but Not Non‐Atopic Dermatitis in Asian Adults: Evidence From a Cross‐Sectional Study

Clinical &Experimental Allergy, EarlyView.
Jun Jie Lim, Jia Yi Karen Wong, Zongxun Huang, Kavita Reginald, Yee‐How Say, Mei Hui Liu, Fook Tim Chew   +6 more
wiley   +1 more source

Response to Pham et al., "Sensory symptoms of scalp psoriasis are not sensitive scalp syndrome". [PDF]

JAAD Int
Brenaut E, Ficheux AS, Pierre O, Taieb C, Misery L.   +4 more
europepmc   +1 more source

Sex hormone-psoriasis interactions: from sex-specific clinical features to immunoregulatory mechanisms. [PDF]

Front Immunol
Dai Y, Wang Y, Huang Y, Jiang X, Tan J.
europepmc   +1 more source

Economic burden of hidradenitis suppurativa based on healthcare resource utilization: German claims data analysis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Hidradenitis suppurativa (HS) is a chronic, debilitating skin disease affecting approximately 0.1% of the German population. Patients with HS require substantial healthcare resource utilization. This study aimed to assess the economic burden associated with HS in Germany.
Falk G. Bechara, Tanja Tran, Sandeep Kiri, Romy Bley, Kathrin Schlüter, Claudia Grellmann, Sima Melnik, Sylke Schneider‐Burrus   +7 more
wiley   +1 more source

Amelioration of psoriasis-like skin lesions by human amniotic mesenchymal stem cells: insights from multiomics profiling in mice. [PDF]

Front Immunol
Yang L, Miao B, Sun Q, Zhang F, Sun H, Zhou Z, Hu Y, Cui Z, Wang D, Liu C, Zhang L, Hu Q, Cong X.   +12 more
europepmc   +1 more source

Biologic treatments for psoriasis have different anatomical specificities in residual PASI

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Improved understanding of the immunopathogenesis of psoriasis has led to the development of effective targeted therapies, but patients who respond to treatment without total skin clearance have residual disease. The aim of this study was to demonstrate the existence of specific residual disease (or residual PASI ...
Martina Burlando, Irene Schiavetti, Aurora Parodi, Emanuele Cozzani, Luca Mastorino, Eleonora Bongiovanni, Ilaria Salvi, Martina Del Vecchio, Paolo Dapavo   +8 more
wiley   +1 more source

Nail Amino Acid and Trace Element Profiles and Their Association with Clinical Severity in Nail Psoriasis. [PDF]

Clin Cosmet Investig Dermatol
Özen T, Gürel MS, Erdem O, Özçelik D, Pastacı Özsobacı N, Selek Ş, Köktaşoğlu F.   +6 more
europepmc   +1 more source

The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis. [PDF]

Psoriasis (Auckl)
Liang Y, Deng B, Ntawuyamara E, Bachelez H, Wang F, Zhang H, Zhang Z, Li Z, Dang L, Wang Y, Zou X, Wang L, Duan D, Chen H, Zheng W, Huang H, Zhang M, Cai Q, Chen Y, Zhang Y, Lu Z, Ren Y, Huang J.   +22 more
europepmc   +1 more source